Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials von Hegelund Myrbäck, Tove, Prothon, Susanne, Edman, Karl, Leander, Jacob, Hashemi, Mahdi, Dearman, Matthew, Edenro, Goran, Svanberg, Petter, Andersson, Eva-Marie, Almquist, Joachim, Ämmälä, Carina, Hendrickx, Ramon, Taib, Ziad, Johansson, Kicki A, Berggren, Anders R, Keen, Christina M, Eriksson, Ulf G, Fuhr, Rainard, Carlsson, Björn C L

Volltext

ETESIAN: A PHASE 2B STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF AZD8233, A PCSK9-TARGETED ANTISENSE OLIGONUCLEOTIDE, IN PATIENTS WITH DYSLIPIDEMIA von Koren, Michael J., Hofherr, Alexis, Schumi, Jennifer, Rekic, Dinko, Knochel, Jane, Nilsson, Catarina A.M., Rudvik, Anna, Wernevik, Linda, Ryden-Bergsten, Tina, Carlsson, Bjorn C.L.

Volltext

Lifestyle-Gene-Drug Interactions in Relation to the Metabolic Syndrome von Storlien, Len, Huang, Xu Feng, Tapsell, Linda C., Karlsson, A. Cecilia, Niklasson, Maria, Pears, John, Carlsson, Björn C.L.

Volltext

Plasminogen Activator Inhibitor-1 Levels and Activity Decrease After Intervention in Patients with Critical Limb Ischaemia von Björck, M, Lepkowska Eriksson, M, Bylock, A, Steuer, J, Wanhainen, A, Carlsson, B.C.L, Bock, D, Kragsterman, B

Volltext